Pramodini Medicare Limited (NSE:PRAMODINI)

India · Delayed Price · Currency is INR

118.00

-0.10 (-0.08%)

At close: Aug 21, 2026

Market Cap	2.60B
Revenue (ttm)	622.88M +148.4%
Net Income	173.77M +255.1%
EPS	10.41 +111.6%
Shares Out	22.05M
PE Ratio	11.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	421,200
Open	117.00
Previous Close	118.10
Day's Range	116.05 - 118.75
52-Week Range	114.00 - 125.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Pramodini Medicare

Pramodini Medicare Limited provides diagnostic service in India. The company offers radiology, which covers magnetic resonance imaging (MRI), computed tomography (CT scan), X-ray, ultrasound, mammography, Dexa scan, and intervention radiology; clinical laboratory, which includes hematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine, which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography), and nuclear therapy services. It also provides healthca... [Read more]

Industry Medical Laboratories

Founded 2000

Employees 161

Stock Exchange National Stock Exchange of India

Ticker Symbol PRAMODINI

Full Company Profile

Financial Performance

In fiscal year 2026, Pramodini Medicare's revenue was 622.88 million, an increase of 62.90% compared to the previous year's 382.38 million. Earnings were 173.77 million, an increase of 57.58%.

Financial Statements